不安症サプリメントのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anxiety Supplement Market Insights, Forecast to 2028

• レポートコード：QY2207E10361 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の不安症サプリメントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に不安症サプリメントの世界市場のxxx％を占める「マグネシウムサプリメント」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「オンライン販売」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の不安症サプリメントの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの不安症サプリメント市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの不安症サプリメント市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 不安症サプリメントのグローバル主要メーカーには、NOW Foods、MegaFood、Nature's Way、Integrative Therapeutics、Nordic Naturals、Pure Encapsulations、Doctor's Best, Inc.、Organic Indiaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 不安症サプリメント市場は、種類と用途によって区分されます。世界の不安症サプリメント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 マグネシウムサプリメント、ビタミン、L-リジン、クルクミン、その他 【用途別セグメント】 オンライン販売、オフライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 不安症サプリメント製品概要 - 種類別市場（マグネシウムサプリメント、ビタミン、L-リジン、クルクミン、その他） - 用途別市場（オンライン販売、オフライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界の不安症サプリメント販売量予測2017-2028 - 世界の不安症サプリメント売上予測2017-2028 - 不安症サプリメントの地域別販売量 - 不安症サプリメントの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別不安症サプリメント販売量 - 主要メーカー別不安症サプリメント売上 - 主要メーカー別不安症サプリメント価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（マグネシウムサプリメント、ビタミン、L-リジン、クルクミン、その他） - 不安症サプリメントの種類別販売量 - 不安症サプリメントの種類別売上 - 不安症サプリメントの種類別価格 ・用途別市場規模（オンライン販売、オフライン販売） - 不安症サプリメントの用途別販売量 - 不安症サプリメントの用途別売上 - 不安症サプリメントの用途別価格 ・北米市場 - 北米の不安症サプリメント市場規模（種類別、用途別） - 主要国別の不安症サプリメント市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの不安症サプリメント市場規模（種類別、用途別） - 主要国別の不安症サプリメント市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の不安症サプリメント市場規模（種類別、用途別） - 主要国別の不安症サプリメント市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の不安症サプリメント市場規模（種類別、用途別） - 主要国別の不安症サプリメント市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの不安症サプリメント市場規模（種類別、用途別） - 主要国別の不安症サプリメント市場規模（トルコ、サウジアラビア） ・企業情報 NOW Foods、MegaFood、Nature's Way、Integrative Therapeutics、Nordic Naturals、Pure Encapsulations、Doctor's Best, Inc.、Organic India ・産業チェーン及び販売チャネル分析 - 不安症サプリメントの産業チェーン分析 - 不安症サプリメントの原材料 - 不安症サプリメントの生産プロセス - 不安症サプリメントの販売及びマーケティング - 不安症サプリメントの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 不安症サプリメントの産業動向 - 不安症サプリメントのマーケットドライバー - 不安症サプリメントの課題 - 不安症サプリメントの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Anxiety Supplement Market
Due to the COVID-19 pandemic, the global Anxiety Supplement market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Magnesium Supplements accounting for % of the Anxiety Supplement global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period.
China Anxiety Supplement market size is valued at US$ million in 2021, while the US and Europe Anxiety Supplement are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anxiety Supplement landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Anxiety Supplement include NOW Foods, MegaFood, Nature’s Way, Integrative Therapeutics, Nordic Naturals, Pure Encapsulations, Doctor’s Best, Inc. and Organic India, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anxiety Supplement Scope and Segment
Anxiety Supplement market is segmented by Type and by Sales Channel. Players, stakeholders, and other participants in the global Anxiety Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2017-2028.
Segment by Type
Magnesium Supplements
Vitamin
L-Lysine
Curcumin
Others
Segment by Sales Channel
Online Sales
Offline Sales
By Company
NOW Foods
MegaFood
Nature’s Way
Integrative Therapeutics
Nordic Naturals
Pure Encapsulations
Doctor’s Best, Inc.
Organic India
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Anxiety Supplement Product Introduction
1.2 Market by Type
1.2.1 Global Anxiety Supplement Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Magnesium Supplements
1.2.3 Vitamin
1.2.4 L-Lysine
1.2.5 Curcumin
1.2.6 Others
1.3 Market by Sales Channel
1.3.1 Global Anxiety Supplement Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anxiety Supplement Sales Estimates and Forecasts 2017-2028
2.2 Global Anxiety Supplement Revenue Estimates and Forecasts 2017-2028
2.3 Global Anxiety Supplement Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anxiety Supplement Sales by Region
2.4.1 Global Anxiety Supplement Sales by Region (2017-2022)
2.4.2 Global Sales Anxiety Supplement by Region (2023-2028)
2.5 Global Anxiety Supplement Revenue by Region
2.5.1 Global Anxiety Supplement Revenue by Region (2017-2022)
2.5.2 Global Anxiety Supplement Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anxiety Supplement Sales by Manufacturers
3.1.1 Global Top Anxiety Supplement Manufacturers by Sales (2017-2022)
3.1.2 Global Anxiety Supplement Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anxiety Supplement in 2021
3.2 Global Anxiety Supplement Revenue by Manufacturers
3.2.1 Global Anxiety Supplement Revenue by Manufacturers (2017-2022)
3.2.2 Global Anxiety Supplement Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anxiety Supplement Revenue in 2021
3.3 Global Anxiety Supplement Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anxiety Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anxiety Supplement Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anxiety Supplement Sales by Type
4.1.1 Global Anxiety Supplement Historical Sales by Type (2017-2022)
4.1.2 Global Anxiety Supplement Forecasted Sales by Type (2023-2028)
4.1.3 Global Anxiety Supplement Sales Market Share by Type (2017-2028)
4.2 Global Anxiety Supplement Revenue by Type
4.2.1 Global Anxiety Supplement Historical Revenue by Type (2017-2022)
4.2.2 Global Anxiety Supplement Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anxiety Supplement Revenue Market Share by Type (2017-2028)
4.3 Global Anxiety Supplement Price by Type
4.3.1 Global Anxiety Supplement Price by Type (2017-2022)
4.3.2 Global Anxiety Supplement Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global Anxiety Supplement Sales by Sales Channel
5.1.1 Global Anxiety Supplement Historical Sales by Sales Channel (2017-2022)
5.1.2 Global Anxiety Supplement Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
5.2 Global Anxiety Supplement Revenue by Sales Channel
5.2.1 Global Anxiety Supplement Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global Anxiety Supplement Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
5.3 Global Anxiety Supplement Price by Sales Channel
5.3.1 Global Anxiety Supplement Price by Sales Channel (2017-2022)
5.3.2 Global Anxiety Supplement Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America Anxiety Supplement Market Size by Type
6.1.1 North America Anxiety Supplement Sales by Type (2017-2028)
6.1.2 North America Anxiety Supplement Revenue by Type (2017-2028)
6.2 North America Anxiety Supplement Market Size by Sales Channel
6.2.1 North America Anxiety Supplement Sales by Sales Channel (2017-2028)
6.2.2 North America Anxiety Supplement Revenue by Sales Channel (2017-2028)
6.3 North America Anxiety Supplement Market Size by Country
6.3.1 North America Anxiety Supplement Sales by Country (2017-2028)
6.3.2 North America Anxiety Supplement Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Anxiety Supplement Market Size by Type
7.1.1 Europe Anxiety Supplement Sales by Type (2017-2028)
7.1.2 Europe Anxiety Supplement Revenue by Type (2017-2028)
7.2 Europe Anxiety Supplement Market Size by Sales Channel
7.2.1 Europe Anxiety Supplement Sales by Sales Channel (2017-2028)
7.2.2 Europe Anxiety Supplement Revenue by Sales Channel (2017-2028)
7.3 Europe Anxiety Supplement Market Size by Country
7.3.1 Europe Anxiety Supplement Sales by Country (2017-2028)
7.3.2 Europe Anxiety Supplement Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anxiety Supplement Market Size by Type
8.1.1 Asia Pacific Anxiety Supplement Sales by Type (2017-2028)
8.1.2 Asia Pacific Anxiety Supplement Revenue by Type (2017-2028)
8.2 Asia Pacific Anxiety Supplement Market Size by Sales Channel
8.2.1 Asia Pacific Anxiety Supplement Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific Anxiety Supplement Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific Anxiety Supplement Market Size by Region
8.3.1 Asia Pacific Anxiety Supplement Sales by Region (2017-2028)
8.3.2 Asia Pacific Anxiety Supplement Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anxiety Supplement Market Size by Type
9.1.1 Latin America Anxiety Supplement Sales by Type (2017-2028)
9.1.2 Latin America Anxiety Supplement Revenue by Type (2017-2028)
9.2 Latin America Anxiety Supplement Market Size by Sales Channel
9.2.1 Latin America Anxiety Supplement Sales by Sales Channel (2017-2028)
9.2.2 Latin America Anxiety Supplement Revenue by Sales Channel (2017-2028)
9.3 Latin America Anxiety Supplement Market Size by Country
9.3.1 Latin America Anxiety Supplement Sales by Country (2017-2028)
9.3.2 Latin America Anxiety Supplement Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Anxiety Supplement Market Size by Type
10.1.1 Middle East and Africa Anxiety Supplement Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anxiety Supplement Revenue by Type (2017-2028)
10.2 Middle East and Africa Anxiety Supplement Market Size by Sales Channel
10.2.1 Middle East and Africa Anxiety Supplement Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa Anxiety Supplement Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa Anxiety Supplement Market Size by Country
10.3.1 Middle East and Africa Anxiety Supplement Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anxiety Supplement Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 NOW Foods
11.1.1 NOW Foods Corporation Information
11.1.2 NOW Foods Overview
11.1.3 NOW Foods Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 NOW Foods Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 NOW Foods Recent Developments
11.2 MegaFood
11.2.1 MegaFood Corporation Information
11.2.2 MegaFood Overview
11.2.3 MegaFood Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MegaFood Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MegaFood Recent Developments
11.3 Nature’s Way
11.3.1 Nature’s Way Corporation Information
11.3.2 Nature’s Way Overview
11.3.3 Nature’s Way Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nature’s Way Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nature’s Way Recent Developments
11.4 Integrative Therapeutics
11.4.1 Integrative Therapeutics Corporation Information
11.4.2 Integrative Therapeutics Overview
11.4.3 Integrative Therapeutics Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Integrative Therapeutics Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Integrative Therapeutics Recent Developments
11.5 Nordic Naturals
11.5.1 Nordic Naturals Corporation Information
11.5.2 Nordic Naturals Overview
11.5.3 Nordic Naturals Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nordic Naturals Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nordic Naturals Recent Developments
11.6 Pure Encapsulations
11.6.1 Pure Encapsulations Corporation Information
11.6.2 Pure Encapsulations Overview
11.6.3 Pure Encapsulations Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pure Encapsulations Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pure Encapsulations Recent Developments
11.7 Doctor’s Best, Inc.
11.7.1 Doctor’s Best, Inc. Corporation Information
11.7.2 Doctor’s Best, Inc. Overview
11.7.3 Doctor’s Best, Inc. Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Doctor’s Best, Inc. Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Doctor’s Best, Inc. Recent Developments
11.8 Organic India
11.8.1 Organic India Corporation Information
11.8.2 Organic India Overview
11.8.3 Organic India Anxiety Supplement Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Organic India Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Organic India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anxiety Supplement Industry Chain Analysis
12.2 Anxiety Supplement Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anxiety Supplement Production Mode & Process
12.4 Anxiety Supplement Sales and Marketing
12.4.1 Anxiety Supplement Sales Channels
12.4.2 Anxiety Supplement Distributors
12.5 Anxiety Supplement Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anxiety Supplement Industry Trends
13.2 Anxiety Supplement Market Drivers
13.3 Anxiety Supplement Market Challenges
13.4 Anxiety Supplement Market Restraints
14 Key Findings in The Global Anxiety Supplement Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Anxiety Supplement Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Magnesium Supplements
Table 3. Major Manufacturers of Vitamin
Table 4. Major Manufacturers of L-Lysine
Table 5. Major Manufacturers of Curcumin
Table 6. Major Manufacturers of Others
Table 7. Global Anxiety Supplement Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Anxiety Supplement Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Anxiety Supplement Sales by Region (2017-2022) & (Units)
Table 10. Global Anxiety Supplement Sales Market Share by Region (2017-2022)
Table 11. Global Anxiety Supplement Sales by Region (2023-2028) & (Units)
Table 12. Global Anxiety Supplement Sales Market Share by Region (2023-2028)
Table 13. Global Anxiety Supplement Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Anxiety Supplement Revenue Market Share by Region (2017-2022)
Table 15. Global Anxiety Supplement Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Anxiety Supplement Revenue Market Share by Region (2023-2028)
Table 17. Global Anxiety Supplement Sales by Manufacturers (2017-2022) & (Units)
Table 18. Global Anxiety Supplement Sales Share by Manufacturers (2017-2022)
Table 19. Global Anxiety Supplement Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Anxiety Supplement Revenue Share by Manufacturers (2017-2022)
Table 21. Anxiety Supplement Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Anxiety Supplement Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Anxiety Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anxiety Supplement as of 2021)
Table 24. Anxiety Supplement Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anxiety Supplement Product Offered
Table 26. Date of Manufacturers Enter into Anxiety Supplement Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 29. Global Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 30. Global Anxiety Supplement Sales Share by Type (2017-2022)
Table 31. Global Anxiety Supplement Sales Share by Type (2023-2028)
Table 32. Global Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Anxiety Supplement Revenue Share by Type (2017-2022)
Table 35. Global Anxiety Supplement Revenue Share by Type (2023-2028)
Table 36. Anxiety Supplement Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Anxiety Supplement Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 39. Global Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 40. Global Anxiety Supplement Sales Share by Sales Channel (2017-2022)
Table 41. Global Anxiety Supplement Sales Share by Sales Channel (2023-2028)
Table 42. Global Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 43. Global Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 44. Global Anxiety Supplement Revenue Share by Sales Channel (2017-2022)
Table 45. Global Anxiety Supplement Revenue Share by Sales Channel (2023-2028)
Table 46. Anxiety Supplement Price by Sales Channel (2017-2022) & (US$/Unit)
Table 47. Global Anxiety Supplement Price Forecast by Sales Channel (2023-2028) & (US$/Unit)
Table 48. North America Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 49. North America Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 50. North America Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 53. North America Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 54. North America Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 55. North America Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 56. North America Anxiety Supplement Sales by Country (2017-2022) & (Units)
Table 57. North America Anxiety Supplement Sales by Country (2023-2028) & (Units)
Table 58. North America Anxiety Supplement Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Anxiety Supplement Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 61. Europe Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 62. Europe Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 65. Europe Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 66. Europe Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 67. Europe Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 68. Europe Anxiety Supplement Sales by Country (2017-2022) & (Units)
Table 69. Europe Anxiety Supplement Sales by Country (2023-2028) & (Units)
Table 70. Europe Anxiety Supplement Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Anxiety Supplement Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 73. Asia Pacific Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 74. Asia Pacific Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 77. Asia Pacific Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 78. Asia Pacific Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 79. Asia Pacific Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 80. Asia Pacific Anxiety Supplement Sales by Region (2017-2022) & (Units)
Table 81. Asia Pacific Anxiety Supplement Sales by Region (2023-2028) & (Units)
Table 82. Asia Pacific Anxiety Supplement Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Anxiety Supplement Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 85. Latin America Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 86. Latin America Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 89. Latin America Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 90. Latin America Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 91. Latin America Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 92. Latin America Anxiety Supplement Sales by Country (2017-2022) & (Units)
Table 93. Latin America Anxiety Supplement Sales by Country (2023-2028) & (Units)
Table 94. Latin America Anxiety Supplement Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Anxiety Supplement Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Anxiety Supplement Sales by Type (2017-2022) & (Units)
Table 97. Middle East and Africa Anxiety Supplement Sales by Type (2023-2028) & (Units)
Table 98. Middle East and Africa Anxiety Supplement Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Anxiety Supplement Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Anxiety Supplement Sales by Sales Channel (2017-2022) & (Units)
Table 101. Middle East and Africa Anxiety Supplement Sales by Sales Channel (2023-2028) & (Units)
Table 102. Middle East and Africa Anxiety Supplement Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Anxiety Supplement Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Anxiety Supplement Sales by Country (2017-2022) & (Units)
Table 105. Middle East and Africa Anxiety Supplement Sales by Country (2023-2028) & (Units)
Table 106. Middle East and Africa Anxiety Supplement Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Anxiety Supplement Revenue by Country (2023-2028) & (US$ Million)
Table 108. NOW Foods Corporation Information
Table 109. NOW Foods Description and Major Businesses
Table 110. NOW Foods Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. NOW Foods Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. NOW Foods Recent Developments
Table 113. MegaFood Corporation Information
Table 114. MegaFood Description and Major Businesses
Table 115. MegaFood Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. MegaFood Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. MegaFood Recent Developments
Table 118. Nature's Way Corporation Information
Table 119. Nature's Way Description and Major Businesses
Table 120. Nature's Way Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Nature's Way Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Nature's Way Recent Developments
Table 123. Integrative Therapeutics Corporation Information
Table 124. Integrative Therapeutics Description and Major Businesses
Table 125. Integrative Therapeutics Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Integrative Therapeutics Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Integrative Therapeutics Recent Developments
Table 128. Nordic Naturals Corporation Information
Table 129. Nordic Naturals Description and Major Businesses
Table 130. Nordic Naturals Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Nordic Naturals Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Nordic Naturals Recent Developments
Table 133. Pure Encapsulations Corporation Information
Table 134. Pure Encapsulations Description and Major Businesses
Table 135. Pure Encapsulations Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Pure Encapsulations Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Pure Encapsulations Recent Developments
Table 138. Doctor's Best, Inc. Corporation Information
Table 139. Doctor's Best, Inc. Description and Major Businesses
Table 140. Doctor's Best, Inc. Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Doctor's Best, Inc. Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Doctor's Best, Inc. Recent Developments
Table 143. Organic India Corporation Information
Table 144. Organic India Description and Major Businesses
Table 145. Organic India Anxiety Supplement Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Organic India Anxiety Supplement Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Organic India Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Anxiety Supplement Distributors List
Table 151. Anxiety Supplement Customers List
Table 152. Anxiety Supplement Market Trends
Table 153. Anxiety Supplement Market Drivers
Table 154. Anxiety Supplement Market Challenges
Table 155. Anxiety Supplement Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Anxiety Supplement Product Picture
Figure 3. Global Anxiety Supplement Market Share by Type in 2021 & 2028
Figure 3. Magnesium Supplements Product Picture
Figure 4. Vitamin Product Picture
Figure 5. L-Lysine Product Picture
Figure 6. Curcumin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anxiety Supplement Market Share by Sales Channel in 2021 & 2028
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Anxiety Supplement Report Years Considered
Figure 12. Global Anxiety Supplement Sales 2017-2028 (Units)
Figure 13. Global Anxiety Supplement Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anxiety Supplement Revenue 2017-2028 (US$ Million)
Figure 15. Global Anxiety Supplement Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Anxiety Supplement Sales Market Share by Region (2017-2022)
Figure 17. Global Anxiety Supplement Sales Market Share by Region (2023-2028)
Figure 18. North America Anxiety Supplement Sales YoY (2017-2028) & (Units)
Figure 19. North America Anxiety Supplement Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Anxiety Supplement Sales YoY (2017-2028) & (Units)
Figure 21. Europe Anxiety Supplement Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Anxiety Supplement Sales YoY (2017-2028) & (Units)
Figure 23. Asia-Pacific Anxiety Supplement Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Anxiety Supplement Sales YoY (2017-2028) & (Units)
Figure 25. Latin America Anxiety Supplement Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Anxiety Supplement Sales YoY (2017-2028) & (Units)
Figure 27. Middle East & Africa Anxiety Supplement Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Anxiety Supplement Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Anxiety Supplement in the World: Market Share by Anxiety Supplement Revenue in 2021
Figure 30. Global Anxiety Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 32. Global Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 33. Global Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 34. Global Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 35. North America Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 36. North America Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 37. North America Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 38. North America Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 39. North America Anxiety Supplement Sales Share by Country (2017-2028)
Figure 40. North America Anxiety Supplement Revenue Share by Country (2017-2028)
Figure 41. United States Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 44. Europe Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 45. Europe Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 46. Europe Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 47. Europe Anxiety Supplement Sales Share by Country (2017-2028)
Figure 48. Europe Anxiety Supplement Revenue Share by Country (2017-2028)
Figure 49. Germany Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 50. France Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 57. Asia Pacific Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 58. Asia Pacific Anxiety Supplement Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Anxiety Supplement Revenue Share by Region (2017-2028)
Figure 60. China Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 63. India Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 70. Latin America Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 72. Latin America Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 73. Latin America Anxiety Supplement Sales Share by Country (2017-2028)
Figure 74. Latin America Anxiety Supplement Revenue Share by Country (2017-2028)
Figure 75. Mexico Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Anxiety Supplement Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Anxiety Supplement Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Anxiety Supplement Sales Market Share by Sales Channel (2017-2028)
Figure 82. Middle East and Africa Anxiety Supplement Revenue Market Share by Sales Channel (2017-2028)
Figure 83. Middle East and Africa Anxiety Supplement Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Anxiety Supplement Revenue Share by Country (2017-2028)
Figure 85. Turkey Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Anxiety Supplement Revenue (2017-2028) & (US$ Million)
Figure 88. Anxiety Supplement Value Chain
Figure 89. Anxiety Supplement Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---